miR-1285-3p plays a tumor suppressor role in NSCLC by targeting YAP1

来源 :第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 | 被引量 : 0次 | 上传用户:lihuihui1986712
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Objective: Non small cell lung cancer (NSCLC) is one of the most aggressive types of cancer and the leading cause of cancer mortality, yet the pathologic mechanisms underlying its devastating clinical outcome remain elusive.
其他文献
  目的: The incidence rate of leptomeningeal carcinomatosis (LC) has been increased in advanced non-smaU cell lung cancer (NSCLC) patients, especially with EGF
  目的:目前肺鳞癌缺乏有效的分子靶向药物,以成纤维细胞生长因子受体1(FGFR1)为靶点的药物正在国内进行Ⅰ期临床研究,而国内关于FGFR1基因拷贝数报道较少。本研究中国肺鳞癌
  目的: In 2011, the International Association for the Study of Lung Cancer, American Thoracic Society and European Respiratory Society (IASLC/ATS/ERS) propose
  Objective: To observe the PFS (Progression Free Survival) could be extended inadvanced non-small cell lung cancer patients with gradual progression after fa
会议
  Objective: As a poor prognostic cancer, lung cancer which has serious impact on psychological of patients.The patient offen involed in a state of depression
会议
  Objective: Low-dose radiation (LDR) has been proposed to induce an adaptive response in normal cells but not in tumor cells, which may protect normal tissue
会议
  Objective: Lung cancer is a heterogeneous group of malignancies with variable prognosis and is divided into two main groups, small cell lung cancer (SCLC) a
会议
  Objective: Acquiredresistance to standard chemotherapy causes treatment failure in patients with advanced non-small lung cancer (NSCLC).Cancer stem cells (C
会议
  Objective: To evaluate the efficacy of treatment with dose-escalated icotinib after resistance to routine dose of icotinib for the patients of the advanced
会议
  Objective: Lung cancer is the leading cause of cancer mortality worldwide.About 30-40% of patients with lung cancer developed bone metastasis during the cou
会议